Clinical Trial Update: PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color

View source ↗

Summary

Clinical trial update indicating the study evaluating pre-exposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine (Truvada) to prevent HIV-1 infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Philadelphia Fight | Conditions: HIV | Status: COMPLETED